Market Overview
Point-of-care testing in Latin America delivers rapid diagnostic results at or near the patient's location, reducing turnaround times compared to centralized laboratory analysis. The market encompasses glucose meters, infectious disease rapid tests, cardiac markers, pregnancy tests, and emerging molecular diagnostics, serving hospitals, clinics, pharmacies, and remote community health centers.
- •Market valued at approximately $45.5 billion in 2025 with 8.6% annual growth trajectory
- •Encompasses glucose monitoring, infectious disease screening, cardiac and coagulation testing, and lateral flow assays
- •Serves diverse settings from major urban hospitals to rural community health posts
Growth Drivers
The rising burden of chronic diseases including diabetes, cardiovascular conditions, and respiratory illnesses across Latin America has accelerated demand for accessible diagnostic solutions. Post-COVID-19 healthcare investments expanded decentralized testing infrastructure, while universal health coverage initiatives prioritize diagnostics access in underserved regions.
- •High prevalence of diabetes and cardiovascular disease driving demand for rapid monitoring solutions
- •Post-pandemic infrastructure development supporting decentralized diagnostic networks
- •Universal health coverage priorities accelerating localized diagnostic adoption
Segmentation and Regional Analysis
The market spans multiple test categories including infectious diseases, cardiometabolic markers, and emerging molecular diagnostics, with varying adoption rates across Brazil, Mexico, Colombia, and Argentina. High mobile phone penetration averaging 77% creates opportunities for smartphone-connected reader devices and digital result tracking, while Internet of Medical Things deployments expand remote monitoring capabilities.
- •Brazil and Mexico represent largest national markets with significant private and public sector demand
- •Smartphone penetration exceeding 75% enables mobile-enabled diagnostic reader integration
- •IoMT deployments growing across South America for connected health monitoring devices
Trends and Outlook
What are the recent trends and outlook?
Digital health convergence is reshaping point-of-care delivery through connected devices, telehealth integration, and artificial intelligence-powered result interpretation. Regulatory harmonization efforts and local manufacturing incentives are gradually addressing infrastructure and distribution challenges that have historically limited market penetration in smaller economies.
- •Digital health funding growth accelerating integration of diagnostic applications with connected devices
- •Regulatory and infrastructure improvements expected to expand access across Central America and Caribbean markets
- •Frugal innovation approaches developing low-cost, smartphone-enabled diagnostics for resource-limited settings
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.